Phase I and pharmacokinetic study of the novel anthracycline derivative 5-imino-13-deoxydoxorubicin (GPX-150) in patients with advanced solid tumors

Sarah A. Holstein, James C. Bigelow, Richard D. Olson, Robert E. Vestal, Gerald M. Walsh, Raymond J. Hohl

Research output: Contribution to journal › Article › peer-review

7 Scopus citations

Fingerprint

Dive into the research topics of 'Phase I and pharmacokinetic study of the novel anthracycline derivative 5-imino-13-deoxydoxorubicin (GPX-150) in patients with advanced solid tumors'. Together they form a unique fingerprint.

Medicine & Life Sciences